R Series 15 mg is a research product commonly associated with retatrutide, an investigational compound developed for scientific study of metabolic regulation.

Retatrutide acts on three receptor pathways: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. Researchers are investigating how these pathways interact and contribute to metabolic processes, including energy balance, appetite regulation, and glucose homeostasis.

The product is labelled as containing 15 mg. Its identity, composition, and analytical characteristics should be confirmed through manufacturer documentation and batch-specific testing before any technical specifications are published.

Product Specifications

• Product Name: Reta Series

• Compound Identity: Retatrutide

• Labelled Quantity: 15 mg

• Product Form: Vial, if confirmed by the packaging

• Category: Research Compounds

• Research Focus: GIP, GLP-1, and glucagon receptor signalling